Promise and challenge of RNA interference-based therapy for cancer.

@article{Petrocca2011PromiseAC,
  title={Promise and challenge of RNA interference-based therapy for cancer.},
  author={Fabio Petrocca and Judy Lieberman},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 6},
  pages={
          747-54
        }
}
Cancer therapeutics still fall far short of our goals for treating patients with locally advanced or metastatic disease. Until recently, almost all cancer drugs were crude cytotoxic agents that discriminate poorly between cancer cells and normally dividing cells. The development of targeted biologics that recognize tumor cell surface antigens and of specific inhibitors of pathways dysregulated in cancer cells or normal cellular pathways on which a cancer cell differentially depends has provided… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 62 CITATIONS, ESTIMATED 78% COVERAGE

siRNA therapeutics: a clinical reality

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Epigenetic therapy in gastrointestinal cancer: the right combination

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Long noncoding RNAs: regulation, function and cancer.

VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

References

Publications referenced by this paper.
SHOWING 1-10 OF 81 REFERENCES

Zamore PD: Small silencing RNAs: An expanding universe

  • M Ghildiyal
  • Nat Rev Genet
  • 2009
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL